Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early spondyloarthritis: results from the pilot registry ESPIDEP.
Muñoz-Fernández S, de Miguel E, Cobo-Ibáñez T, Carmona L, Steiner M, Descalzo MA, Ferreira A, Balsa A, Martín-Mola E; ESPIDEP Study Group. Muñoz-Fernández S, et al. Clin Exp Rheumatol. 2010 Jul-Aug;28(4):498-503. Epub 2010 Aug 30. Clin Exp Rheumatol. 2010. PMID: 20659413
Compliance in gout patients.
Silva L, Miguel ED, Peiteado D, Villalba A, Mola M, Pinto J, Ventura FS. Silva L, et al. Among authors: peiteado d. Acta Reumatol Port. 2010 Oct-Dec;35(5):466-74. Acta Reumatol Port. 2010. PMID: 21245815 Free article.
Decreased Th17 and Th1 cells in the peripheral blood of patients with early non-radiographic axial spondyloarthritis: a marker of disease activity in HLA-B27⁺ patients.
Bautista-Caro MB, Arroyo-Villa I, Castillo-Gallego C, de Miguel E, Peiteado D, Puig-Kröger A, Martín-Mola E, Miranda-Carús ME. Bautista-Caro MB, et al. Among authors: peiteado d. Rheumatology (Oxford). 2013 Feb;52(2):352-62. doi: 10.1093/rheumatology/kes267. Epub 2012 Oct 11. Rheumatology (Oxford). 2013. PMID: 23065314
The timing of serum infliximab loss, or the appearance of antibodies to infliximab (ATI), is related with the clinical activity in ATI-positive patients with rheumatoid arthritis treated with infliximab.
Plasencia Ch, Pascual-Salcedo D, Alcocer P, Bonilla MG, Villalba A, Peiteado D, Arribas F, Díez J, Lopez-Casla MT, Martín-Mola E, Balsa A. Plasencia Ch, et al. Among authors: peiteado d. Ann Rheum Dis. 2013 Nov;72(11):1888-90. doi: 10.1136/annrheumdis-2013-203353. Epub 2013 Jun 5. Ann Rheum Dis. 2013. PMID: 23740237 No abstract available.
62 results